The SUSTAIN Study Compares the Effects of Sustained and Immediate-release Pramipexole on the noctUrnal Symptoms of paTients With Advanced ParkInsoN's Disease Who Also Take L-Dopa
Clinical trial NCT03521635 · COMPLETED
Trial details
- NCT number
- NCT03521635
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-03
- Primary completion
- 2020-01-07
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.